Metastatic presentation of dermatofibrosarcoma protuberans as massive lower gastrointestinal bleed

  • 0Department of General Surgery, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, Chandigarh, India drbasilms@gmail.com.

|

|

Summary

This summary is machine-generated.

Dermatofibrosarcoma protuberans (DFSP) with fibrosarcomatous change is aggressive. This case highlights a rare instance of jejunal fibrosarcoma presenting as gastrointestinal bleeding, emphasizing the need for close patient monitoring.

Area Of Science

  • Oncology
  • Surgical Pathology

Background

  • Dermatofibrosarcoma protuberans (DFSP) is a rare, locally aggressive skin tumor.
  • Fibrosarcomatous transformation in DFSP increases recurrence and metastatic potential.
  • Gastrointestinal metastasis from DFSP is exceptionally rare.

Observation

  • A woman in her late 30s with a history of DFSP presented with massive lower gastrointestinal bleeding.
  • A jejunal mass was identified as the bleeding source and surgically excised.
  • Histopathology confirmed the jejunal mass as fibrosarcoma.

Findings

  • The patient developed progressive disease with lung nodules, ascites, and abdominal lymphadenopathy post-surgery.
  • The fibrosarcoma likely represented a metastatic or transformed DFSP.
  • Chemotherapy was initiated, with the patient showing good tolerance 3 months postoperatively.

Implications

  • This case underscores the aggressive nature of fibrosarcomatous DFSP.
  • Highlights the rare but severe presentation of gastrointestinal bleeding due to DFSP metastasis.
  • Emphasizes the critical need for vigilant long-term surveillance in DFSP patients with fibrosarcomatous changes due to heightened metastatic risk.

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management 01:28

57

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...

Metastasis 02:30

5.5K

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Inflammatory Bowel Disease I: Ulcerative Colitis 01:27

160

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...